Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative response evaluation of cisplatin + capecitabine versus cisplatin + 5-fluorouracil in advanced gastric carcinoma
TCTR20170715001Not yet recruiting
- Sponsor
- Bangabandhu Sheikh Mujib Medical University
- Start
- Jul 2017
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Trial of cisplatin, capecitabine and fluorouracil in gastric adenocarcinoma (2 arms), sponsored by Bangabandhu Sheikh Mujib Medical University. Planned start Jul 2017; status: not yet recruiting.
02
Drugs
cisplatincapecitabinefluorouracil
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on TCTR20170715001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20170715001.